Gryff Pharmaceuticals Private Limited
About Gryff Pharmaceuticals Private Limited
Data last updated:
Gryff Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the repair services segment of the electronics sector. It was incorporated on 07 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U52609UP2019PTC114476. Its GSTIN is 09AAHCG7220L1ZC (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gaurav Agarwal and Vandana Aggarwal.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 178 Rajendra Nagar Sohan Lal School, Lucknow, Uttar Pradesh, India – 226004.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.03 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹3.14 Cr (net margin 28.5%) and EBITDA of ₹4.23 Cr (EBITDA margin 38.4%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address178 Rajendra Nagar Sohan Lal School, Lucknow, Uttar Pradesh, India – 226004
- IndustryElectrnoics, Repair Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gryff Pharmaceuticals Private Limited
The main business activity of Gryff Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gryff Pharmaceuticals Private Limited FY 2025 filings available
Gryff Pharmaceuticals Private Limited reported revenue of ₹11.03 Cr (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Gryff Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 31% over three years, including 17% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gryff Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.23 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.14 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gryff Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 38.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 28.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gryff Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Gryff Pharmaceuticals Private Limited
Gryff Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Agarwal | Director | 07 Mar 2019 | 7 Years 7 Months | Current |
| Vandana Aggarwal | Director | 07 Mar 2019 | 7 Years 7 Months | Current |
Peer Comparison of Gryff Pharmaceuticals Private Limited
Gryff Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Forgo Pharmaceuticals Private Limited | ₹11.23 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Chandigarh, India |
| Manuma Pharmaceuticals Private Limited | ₹11.16 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Jalgaon, Maharashtra, India |
| Sodum Drugs and Pharmaceuticals Private Limited | ₹11.15 Cr (FY 2022) | •••• | •••• | 485.0% | •••• | Medak, Telangana, India |
| Cygnus Pharmaceuticals Private Limited | ₹11.13 Cr (FY 2018) | •••• | •••• | -36.0% | •••• | Kolkata, West Bengal, India |
| Alzan Pharmaceuticals Private Limited | ₹11.09 Cr (FY 2024) | •••• | •••• | 198.0% | •••• | Barnala, Punjab, India |
| Gryff Pharmaceuticals Private Limited this company | ₹11.03 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Lucknow, Uttar Pradesh, India |
| Cisen Pharmaceuticals India Private Limited | ₹11.03 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Salcette, Goa, India |
| Texas Pharmaceuticals Private Limited | ₹11.03 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Karnal, Haryana, India |
| Biotime Pharmaceuticals Private Limited | ₹10.93 Cr (FY 2025) | •••• | •••• | 716.0% | •••• | Ambernath, Maharashtra, India |
| Hibiscus Pharmaceuticals Private Limited | ₹10.93 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Chennai, Tamil Nadu, India |
| Nilrise Pharmaceuticals Private Limited | ₹10.92 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Gryff Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Gryff Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gryff Pharmaceuticals Private Limited
Gryff Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Gryff Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Gryff Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gryff Pharmaceuticals Private Limited
Gryff Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Gaurav Agarwal was appointed as Director on 07 Mar 2019.
Credit Ratings, Litigation & Regulatory Alerts for Gryff Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gryff Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gryff Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gryff Pharmaceuticals Private Limited
Gryff Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCG7220L1ZC | Uttar Pradesh | Active | 11 Mar 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gryff Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gryff Pharmaceuticals Private Limited
Gryff Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in repair services, within the electronics industry. It was incorporated on 07 March 2019 (7+ years old) and is registered under CIN U52609UP2019PTC114476.
Gryff Pharmaceuticals reported revenue of ₹11.03 Cr for FY 2024 (up 17% YoY).
Gryff Pharmaceuticals has 2 current directors:
- Gaurav Agarwal - Director
- Vandana Aggarwal - Director
Gryff Pharmaceuticals reported a net profit of ₹3.14 Cr (net margin 28.5%) and EBITDA of ₹4.23 Cr (EBITDA margin 38.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gryff Pharmaceuticals is 31% over three years. In the latest year (FY 2024) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gryff Pharmaceuticals is 09AAHCG7220L1ZC, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Gryff Pharmaceuticals is U52609UP2019PTC114476. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gryff Pharmaceuticals was incorporated on 07 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Gryff Pharmaceuticals by revenue are Forgo Pharmaceuticals Private Limited, Manuma Pharmaceuticals Private Limited, Sodum Drugs and Pharmaceuticals Private Limited, Cygnus Pharmaceuticals Private Limited, Alzan Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Gaurav Agarwal was appointed as Director on 07 Mar 2019. Vandana Aggarwal was appointed as Director on 07 Mar 2019.
The registered office of Gryff Pharmaceuticals is at 178 Rajendra Nagar Sohan Lal School, Lucknow, Uttar Pradesh, India – 226004.